NF CU

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameNF CU

Drug Alias NameNF-CU

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionT lymphocytes modulatorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effects

TargetsUpdating

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSynimmune Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSynimmune Gmbh

Active IndicationsN/A

Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A